PARC syndrome

PARC syndrome is an extremely rare genetic disorder whose acronym stands for Poikiloderma, Alopecia, Retrognathism, and Cleft palate. This condition is characterized by a combination of skin, hair, craniofacial, and skeletal abnormalities that are typically present from birth or early infancy. The poikiloderma refers to a distinctive skin change involving patches of hyperpigmentation, hypopigmentation, telangiectasia (small dilated blood vessels), and skin atrophy, which can affect various areas of the body. Alopecia (hair loss or sparse hair) is another hallmark feature, along with retrognathism (a recessed lower jaw) and cleft palate, which can affect feeding and speech development. Additional features that have been reported in affected individuals may include short stature, skeletal anomalies, and other craniofacial dysmorphisms. The condition shares clinical overlap with other poikiloderma-associated syndromes such as Rothmund-Thomson syndrome, though it is considered a distinct entity. The exact genetic basis of PARC syndrome has not been fully elucidated, and the number of reported cases in the medical literature remains very small, making it difficult to fully characterize the natural history of the condition. There is currently no specific cure or targeted therapy for PARC syndrome. Management is supportive and multidisciplinary, focusing on the individual clinical manifestations. This may include surgical repair of cleft palate, orthodontic and maxillofacial interventions for retrognathism, dermatologic care for poikiloderma including sun protection, and monitoring for any associated complications. Speech therapy and nutritional support may also be necessary, particularly in early childhood.

Common questions about PARC syndrome